Investing

Recursion Pharmaceuticals : RXRX

RXRX

Stock Data

$3.39

$0.07 (2.02%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Recursion Pharmaceuticals Inc is a trailblazer in the biotech industry, focusing on revolutionizing drug discovery by merging advancements in biology, chemistry, automation, data science, and engineering. With a robust pipeline of drugs in various clinical trial stages, including treatments for cerebral cavernous malformation, neurofibromatosis type 2, familial adenomatous polyposis, Clostridioides difficile infection, and certain cancers, Recursion is at the forefront of developing innovative therapies. Founded in 2013 and based in Salt Lake City, Utah, the company collaborates with leading entities like Bayer AG and Takeda Pharmaceutical to push the boundaries of medical research.

All Recursion Pharmaceuticals Articles

7 Articles

Michael Williams | Mar 29, 2026 at 8:15 AM EDT

MRNA, SRPT, and KRYS Phase 3 Data Will Shape XBI’s 2026 Performance

SPDR S&P Biotech ETF (NYSEARCA:XBI | XBI Price Prediction) is built around a deceptively simple idea: give every biotech company…

Joey Frenette | Feb 12, 2026 at 10:00 AM EST

2 Biotech Stocks to Buy as AI Drug Discovery Lifts Off

AI-assisted drug discovery isn’t just science fiction anymore, especially as biotechnology and biopharma firms embrace the AI age. Undoubtedly, it’s…

Joey Frenette | Aug 8, 2025 at 11:31 AM EDT

Is Recursion Pharmaceuticals (RXRX) Nvidia’s Key AI Biotech Stake a Buy Amid Innovation Surge?

Recursion Pharmaceuticals (NASDAQ:RXRX) stock is one of those lesser-known mid-cap biotech plays that investors may be interested in buying on…

Rich Duprey | Jul 16, 2025 at 9:54 AM EDT

Should You Buy Nvidia’s Secret Investment Portfolio’s Biggest AI Stock Investment?

Nvidia’s Strategic AI Vision Nvidia (NASDAQ:NVDA | NVDA Price Prediction) has solidified its position as the backbone of the artificial…

Rich Duprey | Apr 4, 2025 at 10:31 AM EDT

Nvidia’s (NVDA) Secret Investment Portfolio Is 100% Invested in 5 AI Stocks

Because Nvidia (NASDAQ:NVDA | NVDA Price Prediction) has become the face of artificial intelligence, investors tend to view it as…

Joey Frenette | Feb 2, 2025 at 7:40 PM EST

Cathie Wood’s Top Biotech Plays for February

Don’t look now, but Cathie Wood of Ark Invest is fresh off an impressive comeback year, with her broader basket…

Rich Duprey | Sep 7, 2024 at 8:01 AM EDT

Cathie Wood’s Stock Shuffle: 1 Stock She’s Loving, 1 She’s Leaving

Investors either love Cathie Wood or hate her. The founder of the Ark Invest family of exchange-traded funds can either…